GWS
AZN icon

Glassman Wealth Services’s AstraZeneca AZN Stock Holding History

Glassman Wealth Services’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-881
Closed -$119K – 358
2023
Q4 		$119K Buy
881
+63
+8% +$8.19K 0.02% 266
2023
Q3 		$111K Buy
818
+173
+27% +$23.6K 0.02% 257
2023
Q2 		$92.3K Sell
645
-1
-0.2% -$147 0.01% 276
2023
Q1 		$89.6K Buy
646
+33
+5% +$4.44K 0.02% 278
2022
Q4 		$83.1K Buy
613
+11
+2% +$1.38K 0.02% 302
2022
Q3 		$66K Buy
602
+23
+4% +$2.92K 0.01% 324
2022
Q2 		$77K Sell
579
-101
-15% -$13.3K 0.02% 303
2022
Q1 		$90K Buy
680
+160
+31% +$19.2K 0.02% 280
2021
Q4 		$61K Buy
520
+39
+8% +$4.59K 0.01% 330
2021
Q3 		$58K Buy
481
+150
+45% +$17.5K 0.01% 328
2021
Q2 		$40K Buy
331
+60
+22% +$6.58K 0.01% 397
2021
Q1 		$27K Sell
271
-679
-71% -$68.3K 0.01% 445
2020
Q4 		$95K Buy
950
+274
+41% +$29K 0.02% 235
2020
Q3 		$74K Buy
676
+653
+2,839% +$72.6K 0.02% 242
2020
Q2 		$2K Hold
23
– – ﹤0.01% 822
2020
Q1 		$2K Buy
23
+7
+44% +$659 ﹤0.01% 674
2019
Q4 		$2K Buy
+16
New +$1.51K ﹤0.01% 726
2018
Q4 		– Sell
-122
Closed -$10K – 779
2018
Q3 		$10K Buy
122
+27
+28% +$2.04K ﹤0.01% 386
2018
Q2 		$7K Hold
95
– – ﹤0.01% 400
2018
Q1 		$7K Hold
95
– – ﹤0.01% 383
2017
Q4 		$7K Buy
+95
New +$6.41K ﹤0.01% 361
2017
Q1 		– Sell
-44
Closed -$2K – 570
2016
Q4 		$2K Buy
+44
New +$2.5K ﹤0.01% 494

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Glassman Wealth Services's AZN Position: Q1 2024 in Review

Glassman Wealth Services sold out of AstraZeneca (AZN) in Q1 2024, closing a stake of 881 shares — an estimated $119K sold.

Glassman Wealth Services first reported a position in AZN in Q4 2016 and held it in 22 quarters. The position peaked at $119K in Q4 2023. 1,142 funds tracked by Wall St. Rank hold AZN as of Q1 2024.

  • Glassman Wealth Services reported no remaining AstraZeneca position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 881 AstraZeneca shares in Q1 2024, an estimated $119K.
  • Glassman Wealth Services first reported a position in AstraZeneca in Q4 2016 and held it in 22 quarters.
  • Glassman Wealth Services's AstraZeneca position peaked at $119K in Q4 2023.
  • 1,142 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.